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a  b  s  t  r  a  c  t
Teladorsagia  circumcincta  is a  major  cause  of  ovine  parasitic  gastroenteritis  in  temperate  climatic  regions.
The development  of  high  levels  of  anthelmintic  resistance  in  this  nematode  species  challenges  its  future
control.  Recent  research  indicates  that many  parasite  species  release  extracellular  vesicles  into  their
environment,  many  of  which  have  been  classiﬁed  as  endocytic  in  origin,  termed  exosomes.  These vesicles
are  considered  to play important  roles  in the intercellular  communication  between  parasites  and  their
hosts,  and  thus  represent  potentially  useful  targets  for  novel  control  strategies.  Here,  we  demonstrate
that exosome-like  extracellular  vesicles  can  be  isolated  from  excretory-secretory  (ES) products  released
by T. circumcincta  fourth  stage  larvae  (Tci-L4ES).  Furthermore,  we  perform  a comparative  proteomic
analysis  of vesicle-enriched  and  vesicle-free  Tci-L4ES.  Approximately  73%  of  the  proteins  identiﬁed  in
the  vesicle-enriched  fraction  were  unique  to this  fraction,  whilst  the remaining  27% were  present  in  both
vesicle-enriched  and  vesicle-free  fraction.  These  unique  proteins  included  structural  proteins,  nuclear
proteins,  metabolic  proteins,  proteolytic  enzymes  and  activation-associated  secreted  proteins.  Finally,
we demonstrate  that  molecules  present  within  the  vesicles-enriched  material  are  targets  of  the  IgA  and
IgG response  in T. circumcincta  infected  sheep,  and  could  potentially  represent  useful  targets  for  future
vaccine  intervention  studies.
©  2016  Elsevier  B.V.  All  rights  reserved.. Introduction
Teladorsagia circumcincta is the principal cause of ovine para-
itic gastroenteritis (teladorsagiosis) in temperate climatic regions
nd has been reported as the most predominant nematode species
n ovine ﬂocks in the UK (Bartley et al., 2003; Burgess et al.,
012). In the northern hemisphere, teladorsagiosis is usually seen
rom July to October, coincident with an exponential increase in
nfective third stage larvae (L3) on the pasture on which the ani-
als graze. The main clinical manifestations are reduced weight
ain/condition loss and dehydration due to diarrhoea (Scott, 2007).
aecal contamination of the ﬂeece in the perineal area may  also
ttract blowﬂies, which can lead to myiasis. Teladorsagiosis has
 signiﬁcant economic impact on the industry: studies have esti-
∗ Corresponding author.
E-mail address: Thomas.Tzelos@moredun.ac.uk (T. Tzelos).
ttp://dx.doi.org/10.1016/j.vetpar.2016.03.008
304-4017/© 2016 Elsevier B.V. All rights reserved.mated that losses in excess of £84 million per annum in the UK
are associated with ovine parasitic gastroenteritis due to reduced
productivity and the cost of the treatment alone (Nieuwhof and
Bishop, 2005), with T. circumcincta being the major contributor.
Moreover, the cost of sub-clinical infection, which is likely to be sig-
niﬁcant, is not included in the above ﬁgures (Nieuwhof and Bishop,
2005).
Control of T. circumcincta is largely based on the administra-
tion of broad spectrum anthelmintics (Kohler, 2001); however,
resistance to these drugs appears to be widespread including
reports of multiple drug resistant T. circumcincta isolates (Sargison,
2011; Wrigley et al., 2006). The introduction of two  new classes
of anthelmintic, monepantel in 2008 (Kaminsky et al., 2008) and
derquantel in 2010 (Little et al., 2010), have helped to ﬁll the
gaps created in the control management of parasitic helminths.
However, recent studies have shown that T. circumcincta and
Trichostrongylus colubriformis have developed resistance to mon-
epantel (Scott et al., 2013) and although derquantel is still effective
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n sheep, experience from other anthelmintic drug classes would
uggest that development of resistance to derquantel is likely.
Vaccination represents an alternative control strategy against
. circumcincta as sheep develop protective immunity against the
arasite after experimental multiple infections (Seaton et al., 1989;
mith et al., 1983). Recent work has identiﬁed several vaccine
andidates (Nisbet et al., 2010a, 2009, 2010b, 2011; Redmond
t al., 2006) and a “cocktail” of eight recombinant proteins tar-
eting the fourth larval stage of T. circumcincta, which is the
tage most intimately associated with the host, has been shown
o stimulate signiﬁcant levels of protection against experimen-
al T. circumcincta challenge (Nisbet et al., 2013). However, the
evels of protection achieved using this recombinant protein vac-
ine were variable, with mean reductions in egg output and adult
orm burdens ranging from 58 to 70% and 56 to 75%, respec-
ively, over two replicated experimental trials (Nisbet et al., 2013).
hese data indicate that further optimisation of the vaccine may  be
equired.
Extracellular vesicles (EVs) are membrane vesicles which orig-
nate from either endosomal membranes (exosomes) or plasma
embranes (microvesicles) (Raposo and Stoorvogel, 2013). These
esicles exhibit differences size ranges, with exosomes ranging
etween 30 and 100 nm (Thery et al., 2006; Urbanelli et al.,
013) and microvesicles ranging between 100 and 1000 nm in size
Muralidharan-Chari et al., 2010). EVs can be secreted by multi-
le mammalian cell types and the nature and function of these
esicles, and exosomes in particular, has been intensively studied
ver the last decade (Bobrie et al., 2011; Couzin, 2005; Mathivanan
t al., 2010; Montaner et al., 2014; Simons and Raposo, 2009; Thery,
011). Growth in this ﬁeld is largely due to the discovery that
xosomes play a key role in intercellular signalling and cell–cell
ommunication; for example, B-lymphocytes (Raposo et al., 1996)
nd dendritic cells (Zitvogel et al., 1998) secrete exosomes which
ontain molecules that affect host immune responses (Andreola
t al., 2002; Thery et al., 2002).
Research regarding EVs has now expanded to other organ-
sms including parasitic helminths (Montaner et al., 2014). Studies
howed that the trematodes Fasciola hepatica and Echinostoma
aproni actively release exosomes (Chaiyadet et al., 2015; Marcilla
t al., 2012), as do the nematode species, Caenorhabditis elegans
Liegeois et al., 2006), Heligmosomoides polygyrus (Buck et al., 2014)
nd Trichuris suis (Hansen et al., 2015). Marcilla et al. (2012) showed
hat rat intestinal cells actively take up exosomes secreted by F.
epatica and E. caproni. A recent study demonstrated that small
NAs contained in exosomes secreted by H. polygyrus can regu-
ate genes of the host (mouse) innate immune system (Buck et al.,
014). These observations support the hypothesis that exosomes
lay roles in host-parasite communication. Furthermore, based on
hese observations, it has been suggested that exosomes could
ontain candidates for vaccines and/or targets for pharmaceutical
ntervention (Marcilla et al., 2012). To our knowledge there have
een no reports on whether ruminant parasitic nematodes release
Vs.
The work here examined whether EVs could be found in the
xcretory/secretory (ES) products of T. circumcincta. We  focused
n ES material from fourth stage larvae (L4) as previous studies
ave indicated that local humoral and cellular responses to this
arval stage are critical in the acquisition of protective immunity
n lambs (Smith et al., 1986, 1985; Stear et al., 1995; Strain et al.,
002). Furthermore, a detailed proteomics analysis was conducted
o characterize the contents of these vesicles. Finally, an impor-
ant consideration was to examine whether the vesicle proteins
re targets of the host immune response, which would provide evi-
ence of their release in vivo. Thus, immunoblots were performed
o examine the immunogenicity of the contents of EVs released by
. circumcincta.itology 221 (2016) 84–92 85
2. Materials and methods
2.1. Parasite material
EVs were prepared from the ES products of T. circumcincta L4
(Tci-L4ES). The L4 were harvested following methods described
previously (Knox and Jones, 1990; Redmond et al., 2006; Smith
et al., 2009). Brieﬂy, 5 helminth-free lambs were infected, each
with approximately 150,000 T. circumcincta L3 (strain MTci2;
an anthelmintic-susceptible laboratory isolate from Moredun
Research Institute). Seven days later, the lambs were euthanized
to retrieve the L4. Each abomasum was  removed and processed
individually. The L4 were retrieved from the mucosa and from
the abomasal contents as described previously (Knox and Jones,
1990). The L4 were pooled, washed with Phosphate Buffered
Saline (PBS) and cultured in nematode culture medium [RPMI
1640 Gibco®, Life technologiesTM (500 ml)  supplemented with
sterile l- glutamine (10 ml  of 100 mM),  D-glucose solution (5 g
in 50 ml), penicillin/streptomycin (5 ml  of 10,000 g/ml), ampho-
tericin B (62.5 mg), gentamycin sulphate (12.5 mg) and Hepes
solution (10 ml;  1 M Sigma-Aldrich)] as described in previously
published methods (Redmond et al., 2006).
The protocol for the collection of the ES material after 24, 48 and
72 h of culture was based on previously published studies (Smith
et al., 2009). The pooled ES products from these time-points were
ﬁltered using a 0.22 m syringe ﬁlter (millex® GP). The ﬁltered ES
products were divided into two  equal aliquots (one to be processed
for EVs puriﬁcation and the other for total Tci-L4ES preparation) and
frozen at −80 ◦C until further processing.
2.2. Extracellular vesicle puriﬁcation
EVs puriﬁcation was carried out following the protocol
described in Buck et al. (2014). Brieﬂy, Tci-L4ES samples were
thawed at room temperature and ultracentrifuged at 100,000 × g
for 2 h using a SW40 swing out rotor (cooled overnight at 4 ◦C). The
supernatant (termed EV-free Tci-L4ES) was removed and stored at
−80 ◦C prior to processing. Pelleted material was washed twice
with 12.5 ml  PBS. After each wash, the samples were ultracen-
trifuged at 100,000 × g for 2 h and the supernatant was removed.
Finally, pelleted material was re-suspended in 100 l PBS (termed
EV-enriched Tci-L4ES) and protein concentration measured with
Qubit® 2.0 Fluorometer (Life technologiesTM). An aliquot of the
pelleted material was immediately processed for microscopy as
described below, and the remaining material stored at −80 ◦C prior
to proteomic analysis.
2.3. Transmission electron microscopy (TEM)
An aliquot (8 l) of the pelleted material from 2.2 was ﬁxed with
an equal volume of paraformaldehyde 4% (Fisher scientiﬁc). The
sample was  prepared by the Electron Microscopy (EM) unit of the
University of Edinburgh (School of Biological Sciences, King’s Build-
ings). The technicians of the EM unit prepared the sample for the
TEM as described in Buck et al., 2014.
2.4. Concentration of total and EV-free Tci-L4ES
Total Tci-L4ES and EV-free Tci-L4ES were thawed at room tem-
perature and Amicon Ultra-15 centrifugal ﬁlter units (MWCO
10 kDa; Sigma Aldrich) were used to concentrate the material
according to the manufacturer’s instructions to a ﬁnal volume of
∼1 ml.  Finally, the ﬁlter units were washed twice with pre-chilled
PBS to buffer exchange the material into PBS. The concentration of
the protein in these samples was  measured using the Pierce® BCA
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rotein Assay kit (Thermo scientiﬁc) based on the manufacturer’s
rotocol.
.5. Protein proﬁles of the EV-enriched, the EV-free and total
ci-L4ES products
To examine the protein proﬁle of EV-enriched, EV-free and total
ci-L4ES, 2 g of each sample were subjected to electrophore-
is. The samples were denatured at 70 ◦C for 10 min  after adding
uPAGE® LDS sample buffer (4X; Life TechnologiesTM) and 10X
uPAGE® sample reducing agent (Life TechnologiesTM). Following
he denaturing step, the samples (2 g protein; 10 l total vol-
me  each sample) were subjected to electrophoresis on NuPAGE®
ovex® Bis-Tris 4–12% mini gels (Life TechnologiesTM) under
educing conditions using NuPAGE® MES  SDS running buffer (Life
echnologiesTM). The proteins were stained with SimplyBlueTM
afeStain (Life TechnologiesTM) based on the manufacturer’s
nstructions. An identical replicate NuPAGE® gel was prepared as
bove and the proteins were stained with SilverQuestTM Silver
taining Kit (Life TechnologiesTM) according to the manufacturer’s
nstructions.
.6. Proteomic analysis of EV-enriched and EV-free Tci-L4ES
Preparations that were conﬁrmed to contain vesicles by TEM
EV-enriched Tci-L4ES) and concentrated EV-free Tci-L4ES were
ubjected to proteomic analysis. Approximately 10 g of the
V-enriched and 10 g of the EV-free Tci-L4ES products were
repared, subjected to electrophoresis on NuPAGE® Novex® Bis-
ris 4–12% mini gels (Life TechnologiesTM) and stained with
implyBlueTM SafeStain (Life TechnologiesTM) as described above
section 2.5). The intact NuPAGE® gel was submitted to the More-
un Proteomics Facility (Moredun Research Institute) for liquid
hromatography-electrospray-ionisation tandem mass spectrom-
try (LC-ESI–MS/MS) analysis as described previously (Smith et al.,
009). Deconvoluted MS/MS  data in.mgf (Mascot Generic Format)
ormat was imported into ProteinScapeTM V3.1 (Bruker Dalton-
cs) proteomics data analysis software for downstream database
ining of both Nembase4 (http://www.nematodes.org/nembase4/
 and a cognate T. circumcincta transcriptomic database (Ellis
t al., 2014) utilising the MascotTM V2.4.1 (Matrix Science) search
lgorithm. The protein content of each individual gel slice was
stablished using the “Protein Search” feature of ProteinScapeTM,
hilst separate compilations of the proteins contained in all 24 gel
lices for each sample were produced using the “Protein Extrac-
or” feature of the software. Mascot search parameters were set in
ccordance with published guidelines (Taylor and Goodlett, 2005)
nd to this end, ﬁxed (carbamidomethyl “C”) and variable (oxida-
ion “M”  and deamidation “N,Q”) modiﬁcations were selected along
ith peptide (MS) and secondary fragmentation (MS/MS) tolerance
alues of 0.5 Da whilst allowing for a single 13C isotope. Molecu-
ar weight search (MOWSE) scores attained for individual protein
dentiﬁcations were inspected manually and considered signiﬁcant
nly if a) two peptides were matched for each protein, and b) each
atched peptide contained an unbroken “b” or “y” ion series rep-
esented by of a minimum of four contiguous amino acid residues.
verall conﬁdence in protein identiﬁcations was  enhanced by
e-searching the MS  data against a decoy database constructed
hrough the False Discovery Rate (FDR) feature of the Mascot
earch algorithm. Setting the FDR at a stringency of 1% did not
esult in the exclusion of any proteins that were conﬁdently iden-
iﬁed in the original database search and validation. The results in
roteinScapeTM from the Nembase4 search included the sequence
D of each protein. Subsequently, each protein sequence from
embase4 was subjected to a manual Blast procedure (tblastn)
gainst the full NCBInr database to ﬁnd the closest homologousitology 221 (2016) 84–92
protein. Finally, the proteins detected in the EV-enriched sample
were searched in the ExoCarta database (http://www.exocarta.org/
; Mathivanan and Simpson, 2009; Mathivanan et al., 2012), and in
previous publications (Marcilla et al., 2012) to examine whether
they were detected previously as exosome-related proteins. More-
over, they were searched against the results of previous studies that
examined T. circumcincta L4-speciﬁc gene expression (Nisbet et al.,
2008) and the protein proﬁle of total Tci-L4ES (Smith et al., 2009).
2.7. Immunogenicity of the EV-enriched fraction
Immunoblots were performed to test whether serum IgG and
IgA from sheep which had been trickle infected with 2000 T. cir-
cumcincta L3 three times per week for 4 weeks (Nisbet et al.,
2013), bound components of the EV-enriched fraction. Serum sam-
ples were collected at 6 weeks post-infection at a time where
immunity to T. circumcincta, as determined by decreasing faecal
parasite egg output, had developed. Sera from the same sheep
before infection (‘pre-immune’) were used as a negative control.
The immunoblots were conducted as described by Nisbet et al.
(2010b). Brieﬂy, 5 g of each sample (EV-enriched, EV-free and
total Tci-L4ES products) were prepared and subjected to elec-
trophoresis under reducing conditions as described above (section
2.5). The proteins were transferred onto nitrocellulose membranes
(0.2 m pore size; Life TechnologiesTM); the membranes washed
brieﬂy in TNTT (10 mM Tris, 0.5 M NaCl, 0·05% Tween 20, 0.01%
thiomersal, pH 7.4) and incubated in TNTT overnight at 4 ◦C. The
blots were incubated with sheep sera, diluted 1:200 in TNTT, for 1 h
before being washed three times in TNTT (10 min/wash); incubated
for 1 h in donkey anti-sheep/goat IgG horseradish peroxidase (HRP)
conjugate (AbD Serotec) diluted 1:1000 in TNTT; and washed three
times in TNTT (10 min/wash). Peroxidase activity was revealed
using 3,3′-Diaminobenzidine (DAB) as substrate. Essentially the
same protocol was used for the IgA immunoblot but the secondary
antibody was  mouse anti-bovine/ovine IgA (clone K84.2F9, AbD
Serotec) diluted 1:1000 in TNTT followed by a tertiary antibody
[polyclonal rabbit anti-mouse immunoglobulins/HRP conjugate
(Dako) diluted 1:1000 in TNTT]. Peroxidase activity was revealed
using the Amersham ECL Western Blotting system (GE  healthcare
Life sciences) following the manufacturer’s protocol.
3. Results
3.1. Identiﬁcation of extracellular vesicles in Tci-L4ES
The TEM conﬁrmed the presence of vesicles in Tci-L4ES collected
from sheep at 1 week post infection. The majority of the vesi-
cles were visible as small membrane vesicles within the size range
(30–100 nm)  of exosomes (Urbanelli et al., 2013; arrowed, Fig. 1,
panels A and B). One-dimensional protein proﬁles obtained for the
EV-enriched, EV-free and total Tci-L4ES (Fig. 2) showed that the
proﬁle for the EV-enriched fraction was, qualitatively, substantially
different from those of EV-free and total ES preparations.
3.2. Proteomic analysis of the EV-enriched and EV-free Tci-L4ES
Manual inspection of the proteomics dataset revealed 85 and
132 conﬁdently identiﬁed proteins in the EV-enriched and EV-
free fractions, respectively. A total of 23 proteins were common to
the two fractions and the remainder were unique to each (Fig. 3).
As the aim here was to characterize EVs released by T. circum-
cincta L4, the subsequent analysis focussed on proteins identiﬁed
in the EV-enriched sample. The proteins identiﬁed in the EV-
enriched and the EV-free fractions and their closest homologues
are available in supplementary ﬁles S1 and S2, respectively. The
proteins of the EV-enriched fraction were grouped according to
T. Tzelos et al. / Veterinary Parasitology 221 (2016) 84–92 87
Fig. 1. Extracellular vesicles in the ES products of T. circumcincta L4 stage. Panel
A  shows vesicles spread across the optical ﬁeld (examples indicated with black
arrows). Vesicles tend to aggregate which can be seen as the darker areas in panel
A
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Fig. 2. Protein proﬁles of EV-enriched, EV-free and total Tci-L4ES products of T.
circumcincta L4 stage. 2 g of each sample were subjected to electrophoresis under
reducing conditions. Subsequently, the proteins were stained with SilverQuestTM
Silver Staining Kit (Life TechnologiesTM). (examples indicated with red arrows). Panel B shows one vesicle in higher mag-
iﬁcation (black arrow). (For interpretation of the references to colour in this ﬁgure
egend, the reader is referred to the web version of this article.)
road function and these groups are shown in Table 1 and Fig. 4.
he protein groups were as follows: structural proteins (20.7% of
he proteins); metabolic proteins (2.4%); nuclear proteins (4.9%);
ctivation-associated secreted proteins (ASPs; 12.2%); proteolytic
nzymes (8.6%); ES proteins of unknown function (9.8%); cell-to-
ell, cell-to-matrix interaction proteins (2.4%); ribosomal proteins
1.2%); Rab GTPases (6.1%); proteins for which homologues could
e identiﬁed but could not be classiﬁed in the previous categories
11%); and proteins for which no homologues could be identiﬁed
20.7%).
.3. Immunogenicity of EV-enriched, EV-free and total Tci-L4ES
Immunoblotting experiments demonstrated that proteins
resent in the EV-enriched fraction, EV-free and total Tci-L4ES were
ound by IgG (Fig. 5; panel A) and IgA (Fig. 5; panel B) present in
era from T. circumcincta infected sheep, but not in sera from these
heep prior to infection. In both immunoblots, there were bands
hat were strongly bound by IgG or IgA either in the EV-enriched
nd the total Tci-L4ES only (e.g. area between 62 and 98 kDa) or
nly in the EV-free and total Tci-L4ES (e.g. area between 98 and
88 kDa or 28 kDa area). The immunoblot results suggest that the
igher molecular weight molecules are bound more strongly by
erum IgA, whilst a wider range of molecular weight molecules are
ound by serum IgG.
. DiscussionThe work here demonstrated that EVs are present in the ES
roducts from T. circumcincta L4. This developmental stage was
elected, as it is intimately associated with the abomasal glands
f the sheep host (Denham, 1969). Moreover, previous studiesFig. 3. Venn diagram summarizing the number of unique and common proteins in
the EV-enriched and EV-free fractions.
suggest that L4 are targeted by local humoral and cellular immune
responses that are critical in the development of protective immu-
nity (Smith et al., 1986, 1985; Stear et al., 1995; Strain et al., 2002).
Shotgun proteomics analysis revealed that approximately 70% of
the identiﬁed proteins detected in the EV- enriched fraction were
potentially unique to these components with no detectable pres-
ence in the EV-free ES products. Conversely, the remaining 30% of
the proteins identiﬁed in the EV-enriched fraction were also iden-
tiﬁed in EV-free ES. Finally, some contents of the EVs were found to
88 T. Tzelos et al. / Veterinary Parasitology 221 (2016) 84–92
Fig. 4. Summary of the protein groups identiﬁed in the EV-enriched Tci-L4ES fraction.
Fig. 5. Immunoblots of EV-enriched, EV-free and total Tci-L4ES products of T. circumcincta L4 stage probed with sera obtained from T. circumcincta trickle infected sheep.
P 1–3, p
t
b
p
m
f
b
e
e
e
t
panel  A: IgG immunoreactivity; Panel B IgA immunoreactivity. Both panels − Lanes 
o  the trickle infections.
e immunogenic, as they were shown to be bound by IgG and IgA
resent in sera obtained from T. circumcincta infected sheep.
A proportion of the vesicles identiﬁed in Tci-L4ES exhibited the
orphological characteristics of exosomes with a size that varied
rom 30 to 100 nm (Urbanelli et al., 2013). Although exosomes have
een reported in other parasitic helminths (Bernal et al., 2014; Buck
t al., 2014; Chaiyadet et al., 2015; Hansen et al., 2015; Marcilla
t al., 2012; Wang et al., 2015) this is the ﬁrst report, to our knowl-
dge, of extracellular vesicle production and release by a nematode
hat infects ruminants. Following TEM conﬁrmation of EVs being
resent in the ES products, the protein proﬁle of the EV-enrichedrobed with sera from trickle-infected sheep; lanes 4–6 probed with sera taken prior
sample was  compared with protein proﬁles of EV-free and total Tci-
L4ES products. The results suggested that the protein proﬁle of the
EV-enriched sample was different to the proﬁles of the other two
samples, and that the former sample contained protein bands that
were not identiﬁed in the EV-free Tci-L4ES by gel electrophoresis
and staining.
The protocol that we followed did not include an initial lower
speed centrifugation to separate the larger vesicles. Alternatively,
we used a 0.22 m ﬁlter. The aggregations mentioned (Fig. 1) might
reﬂect a mixture of microvesicle fragments and exosomes due
to the break up of larger vesicles with the ﬁlter. As a result, we
T. Tzelos et al. / Veterinary Paras
Table  1
Broad Functional grouping of proteins identiﬁed in the EV-enriched Tci-L4ES.
Protein Number of
proteins
1. Structural proteins
Actina,c 13
WH2  actin-binding 1
Beta-tubulinc 2
Keratina,c 1
2.  Metabolic Proteins
E1-E2 ATPasesc 1
Thioredoxin peroxidasea,c 1
3.  Nuclear proteins
Histonesc 3
Translation elongation factorsc 1
4.  Activation-associated secreted proteins
ASPsa,b 10
5.  Proteolytic enzymes
Cathepsin Fa,b,c 1
Aspartic proteasec 3
Metalloproteasesa,b,c 3
6.  Excretory/Secretory (ES) proteins of unknown function
ES  proteins of unknown functiona 8
7.  Cell to cell, Cell to matrix interactions
Clc-like (integral membrane component of tight junctions)a,c 1
Transmembrane proteina,c 1
8.  Ribosomal proteins
60S ribosomal proteina,c 1
9.  Rab GTPases
Small GTPase Rab familyc 5
10.  Other function
ADP-ribosylation factorc 3
Transthyretin-like proteina,c 1
Saposin Ba 2
Deoxynucleoside kinase 1
DB module family protein 1
Trp-Asp (WD) repeats circular proﬁle proteinc 1
11.  No homology
No homology proteinsa,b,c 17
a Indicates the identiﬁcation of genes belonging to the same groups by Nisbet
et  al., 2008.
b Indicates the identiﬁcation of genes belonging to the same groups by Smith et al.,
2009.
c Indicates the identiﬁcation of the proteins in exosomes derived by other organ-
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by the immune system of the host (Gretes et al., 2012). It has alsosms (ExoCarta database and Marcilla et al., 2012).
ight have missed larger vesicles and the EV populations might
ave been different if an initial lower speed centrifugation was
erformed. Future EV studies should follow protocols that allow
uriﬁcation of different vesicle populations and could include more
ccurate methods of assessing EV size and total concentration,
uch as tunable resistive pulse sensing (Anderson et al., 2015) or
anoparticle tracking analysis (Dragovic et al., 2011). The EV recov-
ry in our study was measured based on the protein content and
his might be considered as problematic since we re-suspended
he EVs in PBS which does not remove potential contaminat-
ng protein complexes, proteins or lipoproteins. Nevertheless, the
roteins that we detected in the EV-enriched and EV-free frac-
ions were considerably different which gives us conﬁdence that
he proteins identiﬁed within the EV-enriched fraction were of
V origin rather than from contaminating proteins within the ES
upernatant.
The proteomic analysis of the EVs revealed a total of 85 pro-
eins in the EV-enriched sample. Of these, 23 proteins were also
ound in the EV-free sample. It is not yet clear whether this set of 23
roteins which were common to both preparations were adventi-
ious or adherent to the EVs during puriﬁcation or if they represent
 set of proteins that are released both in solution in the ES and
n the EVs. The 82 proteins identiﬁed in the EV-enriched fraction
ncluded, among others, structural proteins (e.g. actin, -tubulin);
etabolic proteins (e.g. peroxiredoxin); nuclear proteins (e.g. his-itology 221 (2016) 84–92 89
tone); ASPs; Rab GTPases; metallopeptidases; and several proteins
for which no homologues could be identiﬁed. Genes encoding 56%
of the characterised vesicle proteins were identiﬁed in a previous
transcriptomic study performed on T. circumcincta L4 harvested at
8 days post-infection, but not in the L3 stage (Nisbet et al., 2008).
Some of the remaining vesicle proteins have not been identiﬁed
previously in T. circumcincta and only 16% of the vesicle proteins
characterised here were identiﬁed in a proteomic analysis of total
ES products derived from T. circumcincta larvae harvested at 1-, 3-
and 5 days post infection (Smith et al., 2009).
In terms of comparison with EVs derived from other organisms,
the analysis here showed that 76% of the EV proteins identiﬁed
in the current study were among molecules previously identiﬁed
in the ExoCarta database (Marcilla et al., 2012; Mathivanan et al.,
2012, 2010; Simpson et al., 2012) and in other published studies
relating to exosomes in helminths (Bernal et al., 2014; Marcilla
et al., 2012). The remaining 24% included proteins such as ASPs and
ES proteins of unknown function (i.e. those previously identiﬁed in
ES material from other parasite species).
Actins and beta-tubulin are structural proteins which repre-
sented 16% and 2% of the proteins identiﬁed in the EV-enriched
sample, respectively, and have been identiﬁed in vesicles of other
organisms (Mathivanan et al., 2012; Mathivanan and Simpson,
2009). Actins are associated with the cytoskeletal microﬁlaments
and beta-tubulin with the cytoskeletal microtubules (Schappi et al.,
2014). Keratin, another cytoskeletal protein, has been also identi-
ﬁed in exosomes originating from human saliva (Xiao and Wong,
2012) and represented 1% of the proteins identiﬁed. The identiﬁ-
cation of keratin in the proteomic analysis could indicate human
contamination, however, the top hit after a tBLASTn search of the
protein identiﬁed in the EV-enriched sample against NCBInr was
an Ostertagia ostertagi partial mRNA for keratin (AJ429146.1, 63%
identities, E value = 2e-71). A subsequent tBLASTn search of the pro-
tein identiﬁed in the exosome-enriched sample against the human
nucleotide collection resulted in no signiﬁcant similarities. WH2
actin-binding protein (1% of the proteins identiﬁed here), associ-
ated with actin assembly, has not been detected in exosomes from
any other organism based on information in ExoCarta (Carlier et al.,
2013). Nevertheless, there are other actin-binding proteins in the
ExoCarta database, such as coronin and moesin. It has been sug-
gested that these structural proteins might be associated with the
exosome production (Wubbolts et al., 2003).
The metabolic proteins that were identiﬁed in the T. circumcincta
EV-enriched fraction (Na/K-ATPase and thioredoxin peroxidase; 1%
of the proteins each) are also present in the ExoCarta database. Ce-
EAT-6 is a Na/K-ATPase and has been shown to interact with ATP
and to have sodium:potassium-exchanging ATPase activity (Davis
et al., 1995). C. elegans Ce-eat-6 mutations have been associated
with paralysis of the pharyngeal muscles in C. elegans (Davis et al.,
1995). Moreover, studies in the trematode, Schistosoma mansoni,
have shown that Na/K-ATPase has been associated with the acqui-
sition of resistance to complement after the parasite has penetrated
the skin (Tarrab-Hazdai et al., 1997) but there are no published
studies to show whether or not this ATPase is found in the EVs of
this species.
Thioredoxin peroxidase, also known as peroxiredoxin, was
identiﬁed in the T. circumcincta EV-enriched sample. This is an
antioxidant enzyme that is considered as a damage-associated
molecular pattern molecule (DAMP), but also as a pathogen-
associated molecular pattern molecule (PAMP) (Medzhitov, 2007;
Robinson et al., 2010b). Peroxiredoxins are thought to play a role in
the survival of parasites against reactive oxygen species generatedbeen proposed that helminth peroxiredoxins are homologous to
host DAMPs and are responsible for the modulation of the immune
response (Dalton et al., 2013; Robinson et al., 2010b). In F. hepatica,
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hese molecules have been shown to help direct the immune sys-
em towards a Th2-type response, thought to be favourable for the
arasites’ development in the host (Dalton et al., 2013; Robinson
t al., 2010a). Peroxiredoxin has also been found in exosomes of
. hepatica and in E. caproni (Marcilla et al., 2012). Peroxiredoxin
as been proposed as a potential vaccine candidate in Fasciola spp.,
ue to its immunomodulatory properties (Robinson et al., 2010a,
010b) but vaccine trials with recombinant peroxiredoxin in goats
nd buffaloes did not show signiﬁcant levels of protection (Mendes
t al., 2010; Raina et al., 2011).
ASPs represented a notable proportion (12%) of the proteins
dentiﬁed in the EVs. These proteins have not yet been described in
he ExoCarta database, which could be explained by the fact that
SPs are nematode-speciﬁc (Parkinson et al., 2004). The precise
unction of nematode ASPs is still unknown but it is suggested
hat these proteins might act as virulence factors that manipu-
ate host immune responses and contribute to parasite survival
n the host (Asojo et al., 2005; Hawdon et al., 1996, 1999). More-
ver, ASPs have been identiﬁed as vaccine candidates against
everal parasitic nematodes, including T. circumcincta (Geldhof
t al., 2002; Ghosh et al., 1996; Kooyman et al., 2000; Nisbet et al.,
013). Here, 10 ASPs were identiﬁed in the exosome-enriched sam-
le (tdc00434, tdc00460, tdc00472, tdc00533, tdc00656, tdc00942,
dc02274, tdc02406, tdc02610 and tdc02887). These proteins were
ot the same as the ASPs identiﬁed by immunoscreening of L4 T.
ircumcincta ES harvested at 5 days post-infection (Nisbet et al.,
010b). This might have been due to the low concentration of
xosomes in total ES products and/or their relatively poor immuno-
enicity. As a result, the novel ASPs revealed from the current
roteomic analysis might be potential vaccine targets.
Another group of proteins, that represented 10% of the proteins
dentiﬁed in the EV-enriched material and have not been previously
dentiﬁed in exosomes of other organisms, are ‘nematode ES pro-
eins’ ascribed no speciﬁc function on the basis of the absence of
haracteristic motifs in their sequences. However, TDP01869 was
ound to share homology with the H. contortus 15 kDa ES protein
Schallig et al., 1997b); HCP02856, HCP06214 and TDP00176 homo-
ogues of the T. circumcincta 20 kDa ES protein (Nisbet et al., 2013);
OP00884, TDP00436 and TDP00589 homologues of the O. ostertagi
putative L3 ES protein’ (De Maere et al., 2002); and TDP00713
omologue of the T. colubriformis 30 kDa glycoprotein (Savin et al.,
990). Each of the homologous proteins (H. contortus 15 kDa ES
rotein, T. circumcincta 20 kDa ES protein, O. ostertagi ‘putative
3 ES protein’ and T. colubriformis 30 kDa glycoprotein) has been
escribed as a vaccine candidate in previous studies. In particular,
n an immunisation trial in sheep using the two native H. contortus
S proteins (the 15 kDa and 24 kDa ES proteins), signiﬁcant pro-
ection against challenge was observed in vaccinated sheep when
ompared with challenge control animals (Schallig et al., 1997a).
he T. colubriformis 30 kDa glycoprotein was found to be protective
n guinea pigs against challenge and was found to reduce worm bur-
ens by 59% in vaccinates compared to challenge controls (Savin
t al., 1990). Furthermore, the T. circumcincta 20 kDa ES protein
Tci-ES20) is one of the components of the eight-protein recombi-
ant ‘cocktail’ mentioned above (Nisbet et al., 2013). The O. ostertagi
putative L3 ES protein’ has been proposed as potential protective
ntigen because it was bound by antibodies from “immune” calves
De Maere et al., 2002), but it remains to be tested in an immu-
isation trial. Putative functions for the above proteins remain to
e established; however, their involvement in several successful
accine trials indicates their potential as valid candidates.
Cathepsin F (Tci-CF-1) was found here in the EVs of T. cir-
umcincta (1%). Tci-CF-1 is the most abundant molecule to be
dentiﬁed in the ES products of T. circumcincta larvae (including
hose harvested at 5, 6 and 9 days post infection) and has been
ound to be a target of IgA responses in previously infected sheepitology 221 (2016) 84–92
(Redmond et al., 2006). A related protein has been identiﬁed in
the exosomes of F. hepatica (Cathepsin L or FheCL; Marcilla et al.,
2012). FheCL has been associated with tissue penetration during
the larvae migration through the host tissue (Dalton and Heffernan,
1989), nutrition (Dalton and Heffernan, 1989; Smith et al., 1993b)
and/or immunomodulation (Chapman and Mitchell, 1982; Dalton
and Heffernan, 1989; Smith et al., 1993a). A more recent study has
shown that FheCL suppressed Th1 immune responses by reducing
the production of IFN- (O’Neill et al., 2001). It has been suggested
that Tci-CF-1 may  have a similar immunomodulatory function
(Redmond et al., 2006). Tci-CF-1 and FheCL have been tested in
trials, which showed signiﬁcant levels of protection against T. cir-
cumcincta in lambs, as part of the eight-protein “cocktail”, (Nisbet
et al., 2013) and F. hepatica in calves (Dalton et al., 1996), respec-
tively.
Rab GTPases represented 6% of the proteins found in the EVs
analysed here. These proteins have been highlighted in previous
studies in helminths (Buck et al., 2014) and were identiﬁed in other
organisms in the ExoCarta database search. In 2010, there were
40 Rab proteins in the ExoCarta database from various studies on
exosomes (Mathivanan et al., 2010). Similar numbers are present
in the database currently. Rab proteins are the largest family of
small GTPases and have been associated with the exosome secre-
tion pathway in cells, for example Rab27 in Hela cells (Ostrowski
et al., 2010), Rab35 in oligodendroglial cells (Hsu et al., 2010) and
Rab11 in erythroleukemia cell lines (Savina et al., 2005). Differ-
ent Rab proteins are involved with different stages of the exosome
secretion pathway (Stenmark, 2009). For example, Rab4, Rab5 and
Rab11 are involved in the early stages, whilst Rab7 and Rab9 in the
later stages (Stenmark, 2009).
The group of proteins with no homology hits identiﬁed com-
prised the largest proportion of proteins in the EV-enriched fraction
(21%). These proteins did not have any motifs identiﬁed in their
sequence that would indicate a potential function. A previous
study has also identiﬁed proteins with no homology and unknown
function (17% of the vesicle proteins) in D. dendriticum- derived
exosomes (Bernal et al., 2014).
An important ﬁnding here was  the demonstrable immunogenic-
ity of components of the EV-enriched Tci-L4ES following their
incubation with serum harvested from sheep trickle-infected with
T.circumcincta over a 6week period. Immunoblotting revealed that
vesicle components were bound by IgG and IgA. This is an indi-
cation that the EVs are secreted in vivo and are not an artefact
from in vitro culture of the parasites. To our knowledge, this is the
ﬁrst demonstration in any parasite species that exosome compo-
nents are targeted by the host antibody response. Thus, it can be
suggested that some of the molecules in the EV-enriched samples
could be vaccine targets since they are bound by the immune sys-
tem of the host during the development of a protective response.
Nevertheless caution is needed because, the immune-recognised
proteins of the EV-enriched Tci-L4ES were not identiﬁed and the
results could be due to the expression of those proteins in worm
locations other than EVs which are exposed to the host immune
response.
5. Conclusion
EVs are released by T. circumcincta L4. The proteomic analysis
revealed several proteins with potential immunomodulatory func-
tion, supporting the earlier hypothesis that helminths use EVs to
simultaneously deliver multiple antigens into host cells and reg-
ulate their function (Dalton et al., 2013). Finally, the binding of
proteins within the EV-enriched fractions by IgA and IgG of pre-
viously infected sheep conﬁrmed their immunogenicity.
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